Log In
BCIQ
Print this Print this
 

MORAb-066

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionHumanized mAb against tissue factor
Molecular Target Tissue factor (TF) (CD142) (thromboplastin)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation U.S. - Orphan Drug (Treat pancreatic cancer)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today